logo

Is the World Trade Organization facing pressure to waive patent rules for COVID-19 vaccines?

Saturday, February 6, 2021
By Gus Fisher
YES

The World Trade Organization is under pressure to waive rules protecting pharmaceutical patents in order to get more COVID-19 vaccines to more of the world more quickly.

India and South Africa, with the backing of 99 other countries and hundreds of advocacy groups, want the WTO to waive parts of the global agreement governing patent rights, allowing more manufacturers to make effective vaccines (or other treatments) without authorization from their developers. Activists argue the industry has been overly restrictive in the past, and note that development of COVID-19 vaccines has been backed by billions of dollars of public support in subsidies and guaranteed purchases.

The WTO normally reaches any agreement by consensus. The U.S., the U.K. and other affluent countries have rejected the proposal outright. They continue to block its progress, most recently at a discussion on Feb. 4.

This fact brief is responsive to conversations such as this one.
ABOUT THE CONTRIBUTOR
Between 2020 and 2022, under close editorial supervision, Gigafact contracted a group of freelance writers and editors to test the concepts for fact briefs and provide inputs to our software development process. We call this effort Gigafact Foundry. Over the course of these two years, Gigafact Foundry writers published over 1500 fact briefs in response to claims they found online. Their important work forms the basis of Gigafact formats and editorial guidelines, and is available to the public on Gigafact.org. Readers should be aware that while there is still a lot of relevant information to be found, not all fact briefs produced by Gigafact Foundry reflect Gigafact's current methods and standards for fact briefs. If you come across any that you feel are out of date and need to be looked at with fresh eyes, don't hesitate to contact us at support@gigafact.org.
FACT BRIEF BY
facebook
twitter
email
email